Tsiporah B. Shore, M.D.

Medical Oncology


Shepherd JD, Shore T, Reece DE, et al. Cyclosporine/Methylprednisone Prophylaxis for Acute Graft-Vs-Host Disease. Bone Marrow Transplantation in 1988; 3:553-558

Shore T, Eisenhauer E, Quirt I, Belanger K, Lohmann R, Silver H, Wielgosz G. A Phase II Study of DuP 937 (Teloxantrone) in Metastatic Malignant Melanoma: A Study of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG). Short Report - Annals of Oncology 1993; 4:695-96

Couban Stephen, Simpson David R., Barnett Michael J, Bredeson Christopher, Hubesch Lothar, Howson – Jan Kang, Shore Tsiporah B., Walker Irwin R, Browett Peter, Messner Hans A., Panzarella Tony, Lipton Jeffrey H., for the Canadian Bone Marrow Transplant Group: A randomized multicenter ceomparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. Blood 2002 100: 1525 – 1531.

ShoreT, Harpel J, Schuster MW, Roboz GJ, Leonard JP, Coleman M, Feldman EJ, Silver RT. A Study of a Reduced-Intensity Conditioning Regimen Followed by Allogeneic Stem Cell Transplantation for Patients with Hematologic Malignancies Using Campath-1H as Part of a Graft-versus-Host Disease Strategy. Biol Blood Marrow Transplant. 2006 Aug;12(8):868-75.

Shore T. Stem Cell Transplantation for Myelodysplastic Syndromes: The Lure of a Cure. Current Hematologic Malignancy Reports. 2007. Vol. 2, No. 7:3-8.

Back to topBack To Top